Drug Screening Market showing an immense improvement by Getting US$ 18 Billion by Time Period of 2021-2032
As per the Future Market Insights research, the drug screening market is forecasted to advance at a tremendous pace with a CAGR of 16% during the forecast period 2022-2032.
A crucial driver of the drug screening market is the overuse
of prescribed drugs and the elevated use of narcotics. According to one of the
recent World Drug Reports, drug and alcohol abuse and consumption are on the
rise globally.
Drug abuse killed nearly 500,000 people, while drug use
disorders resulted in the loss of 18 million years of a healthy life, primarily
due to opioids. Similar increases in alcohol consumption have been observed,
with the consequences being an increase in the incidence of impaired driving.
Request for the
Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14265
The rising consumption of illicit drugs and alcohol will
accelerate the development of drug screening products and services on the road,
fuelling the drug screening market growth.
Some countries, including South Africa, Colombia, Chile,
Argentina, and Canada, consider workplace drug and alcohol testing to violate
employee privacy. Such prohibitions in various countries may impede the adoption
of drug screening devices etc., thereby limiting the overall market
growth.
Several new products, devices, and services have also
received regulatory approval and are being adopted by government agencies and
corporate organizations and are expected to broaden drug screening
market opportunities.
Companies in this market are expected to gain new
opportunities as their business strategies shift toward oral swab drug
tests and the development of the concept of fingerprint-based drug
screening, thereby driving the demand for drug screening devices
etc.,
Furthermore, New Psychoactive Substances (NPS) such as
tryptamines, ketamine, piperazine, and phenethylamines can be considered emerging
trends in the drug screening market. Owing to its low cost and
dependability, urine samples are the most commonly used for testing, ramping
up urine drug tests.
Influenced by factors as mentioned earlier and developments,
the drug screening market is forecasted to touch US$ 11 Bn by 2026.
Key Takeaways:
- By
product type, the consumables segment is likely to dominate the market
since they provide improved solutions to make testing accurate and quick,
accelerating market growth.
- As
it is a quicker and less invasive sample to collect at the roadside, the
oral fluid sample segment is expected to account for a significant drug
screening market share by sample type.
- By
drug type, the cannabis/marijuana segment is forecasted to hold sway over
the drug testing industry since marijuana or cannabis is
the most commonly used illicit substance in critical markets.
- Drug
testing laboratories are predicted to be at the forefront of the market by
end-use, owing to their widespread acceptance and accurate result.
- The drug
screening market size accounted for around US$ 5.3 Bn in 2021.
"North America is projected to reign the market owing
to the government implementing strict workplace testing regulations as well as
expansion strategies followed by players. Furthermore, the region's high
adoption of technologically advanced solutions & favourable reimbursement
scenarios has fuelled the market growth. New organ-on-a-chip platforms enable
more precise and accurate perception of drug effects on the human body, and its
advancements are also contributing to the growth of the North American
drug screening market." asserts an FMI researcher.
Competitive Landscape:
Some of the notable players in the drug screening market are
Premier Biotech (US), Abbott Laboratories (US), Alfa Scientific Designs (US),
OraSure Technologies (US), Shimadzu (Japan), Drägerwerk (Germany), LifeLock
(US), Thermo Fisher Scientific (US), MPD Inc. (US), Omega Laboratories (US),
Psychemedics (US), Roche (Switzerland), and Siemens Healthineers (Germany),
Quest Diagnostics (US).
To capture larger market shares, key companies are pursuing
various growth strategies such as mergers and acquisitions, geographic
expansion, product invention leading to some significant recent
developments in the drug screening market.
- Drager
Safety Canada's Drager drug test 5000 drug testing device
received government approval, making it the country's first roadside oral
fluid drug testing device with active government support.
- Intelligent
fingerprinting limited, based in the United Kingdom, has released the
world's first portable fingerprint drug test to detect and analyze
marijuana, opiates, and amphetamines. The newly launched device allows for
sample collection and analysis in 10 minutes, speeding up the process.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government,
investors, and associated audiences in the healthcare sector to
identify and accentuate vital aspects applicable to product strategy,
regulatory landscape, technology evolution, and other crucial issues to achieve
sustainable success. Our unique approach to gathering market intelligence
equips you in devising innovation-driven trajectories for your business. Know
more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market
intelligence and consulting services, serving clients in over 150 countries.
FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and
India. FMI's latest market research reports and industry analysis
help businesses navigate challenges and make critical decisions with confidence
and clarity amidst breakneck competition. Our customized and syndicated
market research reports deliver actionable insights that drive sustainable
growth. A team of expert-led analysts at FMI continuously tracks emerging
trends and events in a broad range of industries to ensure that our clients
prepare for the evolving needs of their consumers.
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Comments
Post a Comment